Table of Contents

Theranostics

• Clinical

  • 

    You have access

    Initial Experience with [¹⁷⁷Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction

    Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H. Marshall, Steven P. Rowe, Mark C. Markowski, Martin G. Pomper, A. Cahid Civelek, Michael A. Carducci, Samuel R. Denmeade, Jeffrey Young, Kenneth J. Pienta, Channing J. Paller and Lilja B. Solnes

    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1724-1730; DOI: https://doi.org/10.2967/jnumed.124.267723
  • 

    You have access

    Association of Free-to-Total PSA Ratio and ¹⁸F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study

    Rui M. Bernardino, Katherine Lajkosz, Leyi B. Yin, Rashid K. Sayyid, Marian Wettstein, Harkanwal Randhawa, Jessica G. Cockburn, Sayeed Ahmed, Rosita Thomassian, Eleftherios Diamandis, Ur Metser, Alejandro Berlin and Neil E. Fleshner

    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1731-1739; DOI: https://doi.org/10.2967/jnumed.124.267877
  • 

    You have access

    Efficacy and Toxicity of [¹⁷⁷Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data

    Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Sydney Caputo, Elisa Ledet, Abraham Akerele, Abuzar Moradi Tuchayi, Courtney Lawhn-Heath, Tingchang Wang, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Solnes, Thomas A. Hope, Oliver Sartor, Jeremie Calais and Andrei Gafita

    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1740-1744; DOI: https://doi.org/10.2967/jnumed.124.267816
  • 

    You have access

    Cardiac Neuroendocrine Tumor Metastases on ⁶⁸Ga-DOTATATE PET/CT: Identification and Prognostic Significance

    Hwan Lee, Ahmad S. Alhamshari, Vandan Patel, Abhijit Bhattaru, Chaitanya Rojulpote, Mahesh K. Vidula, Daniel A. Pryma and Paco E. Bravo

    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1745-1753; DOI: https://doi.org/10.2967/jnumed.124.267948
  • 

    You have access

    Routine Use of [⁶⁴Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans

    Esben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, Ulrich Knigge, Seppo W. Langer, Jann Mortensen, Lotte Enevoldsen, Peter Oturai and Andreas Kjaer

    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1754-1761; DOI: https://doi.org/10.2967/jnumed.124.267939

• Basic

  • FEATURED BASIC SCIENCE ARTICLE

    • 

      You have access

      Preclinical Evaluation of ²²⁶Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy

      Helena Koniar, Luke Wharton, Aidan Ingham, Ana Paulina Morales Oliver, Helen Merkens, Cristina Rodríguez-Rodríguez, Peter Kunz, Valery Radchenko, Hua Yang, Arman Rahmim, Carlos Uribe and Paul Schaffer

      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1762-1768; DOI: https://doi.org/10.2967/jnumed.124.267999
  • 

    Open Access

    Preclinical Investigation of [²¹²Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model

    Amal Saidi, Tania A. Stallons, Amy G. Wong and Julien J. Torgue

    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1769-1775; DOI: https://doi.org/10.2967/jnumed.124.268101